Tofacitinib citrate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SUNSHINE LAKE PHARM CO LTD
- Publication Date
- 2016-08-17
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] Cross-Referenced Related Applications
[0002] This application claims the priority of the patent application No. 201310464169.8 submitted to the State Intellectual Property Office of China on October 8, 2013, the entire content of which is cited as a reference. technical field
[0003] The invention relates to the field of medicine, in particular to tofacitinib citrate, more specifically to tofacitinib citrate crystal particles, a preparation method for tofacitinib citrate crystal particles, a pharmaceutical composition and the use. Background technique
[0004] Tofacitinib citrate, also known as 3-[(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- Amino]-piperidin-1-yl]-3-oxo-propionitrile citrate, the structure is as shown in formula (I):
[0005]
[0006] PCT application WO2003048162 discloses a new crystal form of tofacitinib citrate and its preparation method, but the crystal particle size prepared according to the method of WO2003048162 is rela...